Unit 7: Facilities & Manufacturing Environment Study Notes

Unit 7: Facilities & Manufacturing Environment

1. Unit Introduction

  • Biopharmaceutical manufacturing facilities are complex structures with intricate controls.

  • Facilities are designed to support Current Good Manufacturing Practices (CGMP).

  • There are higher regulatory, technical, and practical demands on biopharmaceutical facilities compared to other industries.

  • Working in these facilities requires an understanding of facility controls and the technician’s real-world concerns.

2. Biopharmaceutical Facility Regulatory Requirements

  • Facilities must be designed to conduct the processes they house.

  • Relevant regulations are found in 21 CFR §211 Subpart C, which outlines the following sections:
      - Design & Construction
      - Lighting
      - Ventilation, Air Filtration, Air Heating, and Cooling
      - Plumbing
      - Sewage and Refuse
      - Washing and Toilet Facilities
      - Sanitization
      - Maintenance

3. Facility Monitoring and Maintenance

3.1. Common Examples of Building Monitoring Parameters

  • Air Handlers
      - Airflow rate (SCFM)
      - Air temperature
      - Humidity and dew point
      - Pressure at various points in the air handler and ductwork

  • Water Systems
      - Water temperature
      - Conductivity and total organic carbon (measures of purity)
      - Holding tank water level

  • Compressed Air Systems

  • Processing Rooms and Equipment
      - Monitor alarms for utilities and facilities
      - Differential pressure between rooms
      - Continual particle monitoring for clean rooms

3.2. Corrective and Preventative Maintenance

  • Corrective Maintenance (CM): Work performed in response to a system failure; aims to restore control.

  • Preventive Maintenance (PM): Routine work intended to prevent disruptions; based on:
      - OEM recommendations
      - Maintaining instrument performance specifications
      - Meeting regulatory requirements
      - Maximizing uptime and minimizing corrective maintenance
      - Increasing instrument lifespan
      - Ensuring end-user productivity and efficiency

4. Contamination Control

4.1. Environmental Considerations for Processing Areas

  • Air Temperature

  • Humidity

  • Room Pressure Differentials

  • Viable Particulates: Microbiology, including bacteria, yeast, mold, and protozoa.

  • Non-Viable Particulates: Dust and other particles.

4.2. Types of Particulates
4.2.1. Viable Particulates

  • Microbes include:   - Bacteria
      - Yeast
      - Mold
      - Protozoa

  • Bioburden: Total number of microorganisms present.

  • Colony Forming Units (CFU): Unit of measure for bioburden.

4.2.2. Non-Viable Particulates

  • These are measured using a laser particle counter:
      - Measures air volume; detects particles based on size.
      - Reported as count of particles per cubic meter or cubic foot.

4.3. Objectionable Microorganisms

  • Known pathogens that can cause disease in humans; significant concern for parenteral drugs which bypass immune protection.

  • All microorganisms in parenteral drugs are deemed objectionable.

4.4. Spore Forming Bacteria

  • Spores can persist for extended periods and come from gram-positive (e.g., Bacillus, Clostridium) and some gram-negative bacteria.
      - Examples:
        1. Anthrax: Caused by Bacillus anthracis.
        2. Botulism: Caused by Clostridium botulinum.
        3. Tetanus: Caused by Clostridium tetani.

4.5. Endotoxins

  • Large molecules found in the cell wall of gram-negative bacteria; termed pyrogens (fever-inducing).

  • Endotoxins are released when gram-negative bacteria die, requiring testing for detection in facilities.

5. Contamination Control Strategies

  • Aseptic: Defined as free from harmful bacterial or microbial contamination.

  • Strategies include:
      - Cleaning and disinfection
      - Use of airlocks
      - Maintaining differential pressure
      - Segregation for cross-contamination prevention
      - Personnel gowning procedures
      - Material transfer controls
      - Facility qualification protocols

5.1. Cleaning vs. Sanitizing

  • Cleaning: Physical removal of soiled residues from surfaces.

  • Sanitizing: Treatment of cleaned surfaces to reduce disease-causing microorganisms to safe levels.

5.2. Purpose of Cleaning

  • Cleaning processes achieve:
      - Surface preparation for disinfection
      - Removal of foreign matter
      - Prevention of cross-contamination
      - Elimination of biofilms and endotoxins.

  • Cleaning procedures must be validated according to regulatory standards (FDA Guidance).

5.3. Disinfection Process

  • Cleaning methods depend on the surface type and anticipated soils.

  • Technicians typically utilize chemical agents with physical cleaning forces.

  • Regular cleaning schedules are essential; many cleaning agents also serve as sanitizers.

6. Facility Layout and Flows

  • Each facility must support its specific processes, establishing routes for material and personnel.

6.1. Process Areas vs. Non-Process Areas

  • Process Areas: Require controlled environments to support manufacturing activities.

  • Non-Process Areas: Include offices, restrooms, locker rooms, etc.

  • Mechanical Areas: Support processes but aren't controlled.

  • Interstitial Spaces: Serve mechanical systems between floors.

6.2. Clean Rooms

  • Controlled environments designed to reduce contaminants, characterized by:
      - Easier cleanability
      - Controlled temperature and relative humidity (RH)
      - HEPA filtered air
      - Environmental monitoring systems
      - Equipment maintenance protocols

6.3. Cleanroom Classifications

  • Two primary classification standards:
      - ISO: Nine levels of cleanliness based on particle sizes; typically ISO 5 to ISO 9.
      - EMA: Four levels (Grade A to D) with Grade A being the cleanest.

6.4. Cleanroom Construction Requirements

  • Design must support cleanability, appropriate size, proper airflow, and contamination prevention.

  • Hard surfaces for floors, ceilings, walls; sealed openings; and avoidance of gaps between equipment.

6.5. HVAC in Cleanrooms

  • Multi-stage air handlers precondition and filter air to maintain optimal temperature and humidity.

  • HEPA filters focus on capturing particulates (≥0.3 microns).

6.6. Laminar Airflow in Cleanrooms

  • Laminar airflow involves parallel air movement, reducing turbulence to minimize particulate contamination.

7. Aseptic Processing and Clean Room Behavior

7.1. Terminal Sterilization vs. Aseptic Processing

  • Terminal Sterilization: Products are sterilized in their final container using methods like moist heat or gamma irradiation; preferred for parenterals.

  • Aseptic Processing: Involves filling containers in a sterile environment; no subsequent sterilization occurs. Requires high-quality clean rooms.

7.2. Cleanroom Behaviors

  • Best practices to minimize contamination risks include:
      - Move slowly and avoid disturbing airflow
      - Do not touch non-sterile items
      - Keep hands visible; avoid touching gown
      - Refrain from sneezing or coughing

7.3. Aseptic Technique

  • A powerful contamination control method focusing on interaction processes:
      - Touch points
      - Manipulation techniques
      - Hand positioning
      - Tool placement strategies
      - Cleaning timelines
      - Product rejection criteria

  • Aseptic processing demands ongoing awareness to protect integrity.

Conclusion

  • Continuous monitoring, awareness, and strict adherence to protocols are essential in biopharmaceutical facilities to maintain safety and compliance.

  • Regulatory requirements and contamination control strategies underpin successful manufacturing practices.